ILX23-7553
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ILX23-7553, covering 2013-05-30 to 2013-05-30. Get the full timeline:
Most recent: Clinical Trial Update: ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy [Phase 1]